LSIF acts as underwriter in SciBase financing

Life Science Invest Fund (LSIF) is pleased to announce, that we participate as the largest guarantor in the rights issue announced by SciBase this morning. We see SciBase as a compelling case with the Nevisense platform being a groundbreaking product for skin cancer detection and with a strong management team and large owners, who show great support for the company.